Global Animal Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report ID: GIR2212250326 | Category: Pharma & Healthcare | Pages: 104 | Format: PDF | Published Date: January 03,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
According to our (Global Info Research) latest study, the global Animal Stem Cell Therapy market size was valued at USD 63 million in 2022 and is forecast to a readjusted size of USD 80 million by 2029 with a CAGR of 3.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Market competition is intense. Medivet Biologics LLC, VETSTEM BIOPHARMA and J-ARM, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption region of animal stem cell therapy, with a consumption market share nearly 58%. Japan is the second largest supplier of animal stem cell therapy, enjoying production market share nearly 15%.
This report is a detailed and comprehensive analysis for global Animal Stem Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Animal Stem Cell Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Animal Stem Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Animal Stem Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Animal Stem Cell Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Animal Stem Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Animal Stem Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medivet Biologics LLC, VETSTEM BIOPHARMA, J-ARM, U.S. Stem Cell, Inc and VetCell Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Animal Stem Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others Animals
Market segment by Application
Veterinary Hospitals
Research Organizations
Market segment by players, this report covers
Medivet Biologics LLC
VETSTEM BIOPHARMA
J-ARM
U.S. Stem Cell, Inc
VetCell Therapeutics
Celavet Inc.
Magellan Stem Cells
Kintaro Cells Power
Animal Stem Care
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Animal Stem Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Animal Stem Cell Therapy, with revenue, gross margin and global market share of Animal Stem Cell Therapy from 2018 to 2023.
Chapter 3, the Animal Stem Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Animal Stem Cell Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Animal Stem Cell Therapy.
Chapter 13, to describe Animal Stem Cell Therapy research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of Animal Stem Cell Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Animal Stem Cell Therapy by Type
        1.3.1 Overview: Global Animal Stem Cell Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Animal Stem Cell Therapy Consumption Value Market Share by Type in 2022
        1.3.3 Dogs Stem Cell Therapy
        1.3.4 Horses Stem Cell Therapy
        1.3.5 Others Animals
    1.4 Global Animal Stem Cell Therapy Market by Application
        1.4.1 Overview: Global Animal Stem Cell Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Veterinary Hospitals
        1.4.3 Research Organizations
    1.5 Global Animal Stem Cell Therapy Market Size & Forecast
    1.6 Global Animal Stem Cell Therapy Market Size and Forecast by Region
        1.6.1 Global Animal Stem Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Animal Stem Cell Therapy Market Size by Region, (2018-2029)
        1.6.3 North America Animal Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.4 Europe Animal Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Animal Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.6 South America Animal Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Animal Stem Cell Therapy Market Size and Prospect (2018-2029)
2 Company Profiles
    2.1 Medivet Biologics LLC
        2.1.1 Medivet Biologics LLC Details
        2.1.2 Medivet Biologics LLC Major Business
        2.1.3 Medivet Biologics LLC Animal Stem Cell Therapy Product and Solutions
        2.1.4 Medivet Biologics LLC Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Medivet Biologics LLC Recent Developments and Future Plans
    2.2 VETSTEM BIOPHARMA
        2.2.1 VETSTEM BIOPHARMA Details
        2.2.2 VETSTEM BIOPHARMA Major Business
        2.2.3 VETSTEM BIOPHARMA Animal Stem Cell Therapy Product and Solutions
        2.2.4 VETSTEM BIOPHARMA Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 VETSTEM BIOPHARMA Recent Developments and Future Plans
    2.3 J-ARM
        2.3.1 J-ARM Details
        2.3.2 J-ARM Major Business
        2.3.3 J-ARM Animal Stem Cell Therapy Product and Solutions
        2.3.4 J-ARM Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 J-ARM Recent Developments and Future Plans
    2.4 U.S. Stem Cell, Inc
        2.4.1 U.S. Stem Cell, Inc Details
        2.4.2 U.S. Stem Cell, Inc Major Business
        2.4.3 U.S. Stem Cell, Inc Animal Stem Cell Therapy Product and Solutions
        2.4.4 U.S. Stem Cell, Inc Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 U.S. Stem Cell, Inc Recent Developments and Future Plans
    2.5 VetCell Therapeutics
        2.5.1 VetCell Therapeutics Details
        2.5.2 VetCell Therapeutics Major Business
        2.5.3 VetCell Therapeutics Animal Stem Cell Therapy Product and Solutions
        2.5.4 VetCell Therapeutics Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 VetCell Therapeutics Recent Developments and Future Plans
    2.6 Celavet Inc.
        2.6.1 Celavet Inc. Details
        2.6.2 Celavet Inc. Major Business
        2.6.3 Celavet Inc. Animal Stem Cell Therapy Product and Solutions
        2.6.4 Celavet Inc. Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Celavet Inc. Recent Developments and Future Plans
    2.7 Magellan Stem Cells
        2.7.1 Magellan Stem Cells Details
        2.7.2 Magellan Stem Cells Major Business
        2.7.3 Magellan Stem Cells Animal Stem Cell Therapy Product and Solutions
        2.7.4 Magellan Stem Cells Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Magellan Stem Cells Recent Developments and Future Plans
    2.8 Kintaro Cells Power
        2.8.1 Kintaro Cells Power Details
        2.8.2 Kintaro Cells Power Major Business
        2.8.3 Kintaro Cells Power Animal Stem Cell Therapy Product and Solutions
        2.8.4 Kintaro Cells Power Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Kintaro Cells Power Recent Developments and Future Plans
    2.9 Animal Stem Care
        2.9.1 Animal Stem Care Details
        2.9.2 Animal Stem Care Major Business
        2.9.3 Animal Stem Care Animal Stem Cell Therapy Product and Solutions
        2.9.4 Animal Stem Care Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Animal Stem Care Recent Developments and Future Plans
    2.10 Animal Cell Therapies 
        2.10.1 Animal Cell Therapies Details
        2.10.2 Animal Cell Therapies Major Business
        2.10.3 Animal Cell Therapies Animal Stem Cell Therapy Product and Solutions
        2.10.4 Animal Cell Therapies Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Animal Cell Therapies Recent Developments and Future Plans
    2.11 Cell Therapy Sciences
        2.11.1 Cell Therapy Sciences Details
        2.11.2 Cell Therapy Sciences Major Business
        2.11.3 Cell Therapy Sciences Animal Stem Cell Therapy Product and Solutions
        2.11.4 Cell Therapy Sciences Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Cell Therapy Sciences Recent Developments and Future Plans
    2.12 Animacel
        2.12.1 Animacel Details
        2.12.2 Animacel Major Business
        2.12.3 Animacel Animal Stem Cell Therapy Product and Solutions
        2.12.4 Animacel Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Animacel Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Animal Stem Cell Therapy Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Animal Stem Cell Therapy by Company Revenue
        3.2.2 Top 3 Animal Stem Cell Therapy Players Market Share in 2022
        3.2.3 Top 6 Animal Stem Cell Therapy Players Market Share in 2022
    3.3 Animal Stem Cell Therapy Market: Overall Company Footprint Analysis
        3.3.1 Animal Stem Cell Therapy Market: Region Footprint
        3.3.2 Animal Stem Cell Therapy Market: Company Product Type Footprint
        3.3.3 Animal Stem Cell Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
    4.1 Global Animal Stem Cell Therapy Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Animal Stem Cell Therapy Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
    5.1 Global Animal Stem Cell Therapy Consumption Value Market Share by Application (2018-2023)
    5.2 Global Animal Stem Cell Therapy Market Forecast by Application (2024-2029)
6 North America
    6.1 North America Animal Stem Cell Therapy Consumption Value by Type (2018-2029)
    6.2 North America Animal Stem Cell Therapy Consumption Value by Application (2018-2029)
    6.3 North America Animal Stem Cell Therapy Market Size by Country
        6.3.1 North America Animal Stem Cell Therapy Consumption Value by Country (2018-2029)
        6.3.2 United States Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        6.3.3 Canada Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        6.3.4 Mexico Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
7 Europe
    7.1 Europe Animal Stem Cell Therapy Consumption Value by Type (2018-2029)
    7.2 Europe Animal Stem Cell Therapy Consumption Value by Application (2018-2029)
    7.3 Europe Animal Stem Cell Therapy Market Size by Country
        7.3.1 Europe Animal Stem Cell Therapy Consumption Value by Country (2018-2029)
        7.3.2 Germany Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.3 France Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.5 Russia Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.6 Italy Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
8 Asia-Pacific
    8.1 Asia-Pacific Animal Stem Cell Therapy Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Animal Stem Cell Therapy Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Animal Stem Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific Animal Stem Cell Therapy Consumption Value by Region (2018-2029)
        8.3.2 China Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.3 Japan Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.4 South Korea Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.5 India Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.7 Australia Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
9 South America
    9.1 South America Animal Stem Cell Therapy Consumption Value by Type (2018-2029)
    9.2 South America Animal Stem Cell Therapy Consumption Value by Application (2018-2029)
    9.3 South America Animal Stem Cell Therapy Market Size by Country
        9.3.1 South America Animal Stem Cell Therapy Consumption Value by Country (2018-2029)
        9.3.2 Brazil Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        9.3.3 Argentina Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
10 Middle East & Africa
    10.1 Middle East & Africa Animal Stem Cell Therapy Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Animal Stem Cell Therapy Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Animal Stem Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa Animal Stem Cell Therapy Consumption Value by Country (2018-2029)
        10.3.2 Turkey Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
        10.3.4 UAE Animal Stem Cell Therapy Market Size and Forecast (2018-2029)
11 Market Dynamics
    11.1 Animal Stem Cell Therapy Market Drivers
    11.2 Animal Stem Cell Therapy Market Restraints
    11.3 Animal Stem Cell Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
    12.1 Animal Stem Cell Therapy Industry Chain
    12.2 Animal Stem Cell Therapy Upstream Analysis
    12.3 Animal Stem Cell Therapy Midstream Analysis
    12.4 Animal Stem Cell Therapy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Animal Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?